● Latest

A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA) Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment RIG 101 Trial in Healthy Adults and Adults With Asthma

All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Infectious Disease Men's Health Mental Health / Psychiatry Neurology Oncology Rare Diseases Respiratory / COPD / Asthma Rheumatology

Article

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

📅 25 Mar 2026 🕐 1 min read

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Share: 𝕏 Twitter/X 🔗 LinkedIn

Join 10,000+ UK Clinicians

Get weekly clinical updates — guidelines, trials, MHRA alerts — delivered to your inbox. Free for verified HCPs.

By registering you confirm you are a healthcare professional. No spam. Unsubscribe anytime.